TIL Therapy in cSCC and MCC

Abroad (travel likely)RecruitingPHASE2

Conditions

Cutaneous Squamous Cell Carcinoma · Merkel Cell Carcinoma · Metastatic Cutaneous Squamous Cell Carcinoma · Skin Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Karam Khaddour, MD) · karam_khaddour@dfci.harvard.edu · 617-632-6571
Contact: Principal Investigator (Karam Khaddour, MD)

Study leads

Karam Khaddour, MD
Principal Investigator
Dana-Farber Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Beta-only IL-2 ImmunoTherapY Study

Advanced Solid Tumor · Unresectable Solid Tumor · Clear Cell Renal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Diego, United States · San Francisco, United States

Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

Cutaneous Squamous Cell Carcinoma · Skin Cancers - Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Pittsburgh, United States

Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

Merkel Cell Carcinoma · Cutaneous Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1

Tampa, United States

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Solid Tumor · Advanced Cancer · Metastatic Cancer

Abroad (travel likely)RecruitingPHASE1

Tampa, United States · Durham, United States